Pocket-X
Commercial- Indications
- Periodontal disease
Company intelligence / Profile preview
Prudentix
Israelprudentix.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Prudentix develops innovative medical devices using patented formulations with structural properties designed to regenerate tissues. Their lead platform leverages human recombinant amelogenin for applications in dentistry—such as periodontitis treatment—and expanding into orthopedics and dermatology. The company has commercialized at least one product ("Pocket-X gel") with international distribution agreements. Ongoing collaborations include academic partnerships focused on new indications.
- Therapeutic areas
- OtherDermatologyRheumatologyInfectious Diseases
- Modalities
- Recombinant proteinMedical deviceBiologic
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Geistlich Pharma AG (Switzerland)local/international distributorsHadassah Medical Center/Hebrew University of Jerusalem academic collaboration
Beyond the preview
Go deeper on Prudentix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prudentix.